CODA Biotherapeutics Email Format

BiotechnologyCalifornia, United States11-50 Employees

CODA Biotherapeutics is a biotechnology research company developing a chemogenetic platform that enables gene therapy to introduce a tunable switch into target cells. Cells carrying the switch can be activated or inactivated in a dose-dependent manner by a subsequently administered small molecule, with effects limited to the modified cells. The platform aims to modulate the activity of a wide range of cell types where the receptor can be expressed, and it can be tailored to a specific disease by adjusting delivery elements and the route of administration.

The company is based in South San Francisco, California, and is part of the biotechnology research sector with a relatively small team. It has been described as a preclinical-stage biopharmaceutical company focused on neurological disorders, with an initial emphasis on neuropathic pain and epilepsy. In March 2022, CODA named Susan Catalano as chief scientific officer.

Get verified CODA Biotherapeutics emails free

Company overview Employee directory